BMS-298585
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BMS-298585, covering 2012-04-23 to 2012-04-27. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control [Phase 3]